Nayouki Mochida optimistic on Epadel-Read his statement
Nayouki Mochida is Chairman of Mochida in Japan.Epadel is their biggest product according to Nayouki.They are going to sell Epadel on OTC market in Japan.In addition ,they are trying to find Epadel uses in other areas-- launched phase 2 trials as treatment for non-alcohlic Steato Hepatitis.
All these(several) documents in pdfs are available if you search Mochida Corp.
Even in Phar. pdf--Epadel is mentioned. Mochida developed Epadel in Japan--did Jelis trials from 1999-2005 successfully--They sold 562 mil.$ in 2011 (Epadel).
I don't know the potential for Hepatitis--but that must be significant--as Chairman mentioned it.
FYI -Epadel is 90% pure EPA
Being Large does not mean anything.Olympics is the biggest co. in Endoscopy worlwide with close to 1.5 bil.$ sales/year.
It has introduced Capsule Endoscopy since 2007-- hardly selling any in Japan-little in Europe and USA. Given Imaging--small co.dominates this market incl.Japan.
In Japan--people respect their doctors--who are well read.If they think Epadel is better ,then patients will buy Epadel.
Epadel should be available in OTC market soon in Japan.